The role of mitochondrial transition pore, and its modulation, in traumatic brain injury and delayed neurodegeneration after TBI
- PMID: 19481077
- DOI: 10.1016/j.expneurol.2009.05.026
The role of mitochondrial transition pore, and its modulation, in traumatic brain injury and delayed neurodegeneration after TBI
Abstract
Following severe traumatic brain injury (TBI), a complex interplay of pathomechanism, such as exitotoxicity, oxidative stress, inflammatory events, and mitochondrial dysfunction occurs. This leads to a cascade of neuronal and axonal pathologies, which ultimately lead to axonal failure, neuronal energy metabolic failure, and neuronal death, which in turn determine patient outcome. For mild and moderate TBI, the pathomechanism is similar but much less frequent and ischemic cell death is unusual, except with mass lesions. Involvement of mitochondria in acute post-traumatic neurodegeneration has been extensively studied during the last decade, and there are a number of investigations implicating the activation of the mitochondrial permeability transition pore (mPTP) as a "critical switch" which determines cell survival after TBI. Opening of the mPTP is modulated by several factors occurring after a severe brain injury. Modern neuroprotective strategies for prevention of the neuropathological squeal of traumatic brain injury have now begun to address the issue of mitochondrial dysfunction, and drugs that protect mitochondrial viability and prevent apoptotic cascade induced by mPTP opening are about to begin phase II and III clinical trials. Cyclosporin A, which has been reported to block the opening of mPTP, showed a significant decrease in mitochondrial damage and intra-axonal cytoskeletal destruction thereby protecting the axonal shaft and blunting axotomy. This review addresses an important issue of mPT activation after severe head injury, its role in acute post-traumatic neurodegeneration, and the rationale for targeting the mPTP in experimental and clinical TBI studies.
Similar articles
-
Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice.Exp Neurol. 2006 Sep;201(1):253-65. doi: 10.1016/j.expneurol.2006.04.013. Epub 2006 Jun 30. Exp Neurol. 2006. PMID: 16814284
-
Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?J Neurosci Res. 2005 Jan 1-15;79(1-2):231-9. doi: 10.1002/jnr.20292. J Neurosci Res. 2005. PMID: 15573402 Review.
-
Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury.Exp Neurol. 1999 Nov;160(1):226-34. doi: 10.1006/exnr.1999.7197. Exp Neurol. 1999. PMID: 10630207
-
Quantitative detection of the expression of mitochondrial cytochrome c oxidase subunits mRNA in the cerebral cortex after experimental traumatic brain injury.Brain Res. 2009 Jan 28;1251:287-95. doi: 10.1016/j.brainres.2008.11.034. Epub 2008 Nov 21. Brain Res. 2009. PMID: 19063873
-
Mechanisms of secondary brain injury.Eur J Anaesthesiol. 1996 May;13(3):247-68. Eur J Anaesthesiol. 1996. PMID: 8737117 Review.
Cited by
-
Calcium in Neuronal and Glial Response to Axotomy.Int J Mol Sci. 2021 Dec 12;22(24):13344. doi: 10.3390/ijms222413344. Int J Mol Sci. 2021. PMID: 34948141 Free PMC article. Review.
-
Does Ischemia Contribute to Energy Failure in Severe TBI?Transl Stroke Res. 2011 Dec;2(4):517-23. doi: 10.1007/s12975-011-0119-8. Epub 2011 Nov 4. Transl Stroke Res. 2011. PMID: 24323682
-
Mitochondrial dysfunction is an acute response of articular chondrocytes to mechanical injury.J Orthop Res. 2018 Feb;36(2):739-750. doi: 10.1002/jor.23651. Epub 2017 Jul 31. J Orthop Res. 2018. PMID: 28696002 Free PMC article.
-
Traumatic Axonal Injury: Mechanisms and Translational Opportunities.Trends Neurosci. 2016 May;39(5):311-324. doi: 10.1016/j.tins.2016.03.002. Epub 2016 Mar 31. Trends Neurosci. 2016. PMID: 27040729 Free PMC article. Review.
-
A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury.CNS Drugs. 2012 Jul 1;26(7):613-36. doi: 10.2165/11634020-000000000-00000. CNS Drugs. 2012. PMID: 22668124 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources